Clinical benefit in NSCLC: the evidence for gefitinib ('Iressa', ZD1839)

Author: Lynch T.  

Publisher: Elsevier

ISSN: 1359-6349

Source: EJC Supplements, Vol.1, Iss.8, 2003-10, pp. : 17-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract